MedPath

Renal Denervation for the Treatment of Hypertension: A Pilot Safety and Efficacy Study

Not Applicable
Conditions
Hypertension
Interventions
Device: Radio frequency renal denervation system (Golden Leaf GL-06E15A)
Registration Number
NCT02672462
Lead Sponsor
Shanghai Golden Leaf MedTec Co. Ltd
Brief Summary

A single center, self-controlled pilot study on safety and efficacy of renal denervation in treatment of hypertension.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Ages of 18 to 75, male or female;

  • Main renal artery, with or without accessary renal arteries, with length

    • 20mm;
  • Patients who have not taken any anti-hypertensive drugs or have been off drugs for at least 2 weeks, with mean SBP ≥150mmHg and

    • 180mmHg based on at least 3 office blood pressure measurements, or ASBP≥135mmHg and ≤170mmHg based on 24 hr blood pressure monitoring;
  • Agrees to take part in the trial and signs the written, informed consent.

Exclusion Criteria
  • Renal artery abnormalities that are inappropriate for the procedure;
  • Pregnant or plan to become pregnant;
  • History of orthostatic hypotension;
  • Type I diabetes;
  • Estimated GFR<40mL/min/1.73m2;
  • Only one kidney or prior kidney transplantation;
  • Bleeding tendency or other coagulation related diseases;
  • Acute or severe systemic infection;
  • Prior renal artery interventional procedures or prior RDN treatment;
  • History of stroke or TIA;
  • Malignant tumor or end-stage illnesses;
  • Secondary hypertension;
  • Acute coronary events within 2 weeks;
  • Other conditions that deem unsuitable for the procedure, in the opinions of investigators.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Renal denervationRadio frequency renal denervation system (Golden Leaf GL-06E15A)-
Primary Outcome Measures
NameTimeMethod
blood pressure6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Zhongda Hospital

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath